{"product_id":"wc-0efe51bcb5f34c14-50444","title":"Scientific Symposiums International Dermatopathology in Paradise Medical Dermatology to Melanocytic Tumors 2026","description":"\u003ch1 data-pm-slice=\"1 1 []\"\u003eScientific Symposiums International Dermatopathology in Paradise Medical Dermatology to Melanocytic Tumors 2026\u003c\/h1\u003e\r\n\u003ch2\u003eSSI Dermatopathology in Paradise 2026 | Inflammatory Dermatoses, Melanocytic Tumors, Melanoma in Situ, Cutaneous Lymphoma, Alopecia, Vascular Pathology, Pediatric Tumors \u0026amp; Diagnostic Dermatopathology\u003c\/h2\u003e\r\nThe \u003cstrong\u003eScientific Symposiums International Dermatopathology in Paradise Medical Dermatology to Melanocytic Tumors 2026\u003c\/strong\u003e course provides a comprehensive, case-based educational update on diagnostic dermatopathology, inflammatory skin diseases, cutaneous infections, vascular disorders, hair pathology, lymphoid proliferations, pediatric skin tumors, and melanocytic neoplasms.\r\n\r\nOrganized by \u003cstrong\u003eScientific Symposiums International (SSI)\u003c\/strong\u003e, this four-day continuing medical education conference brings together internationally recognized specialists in dermatopathology and dermatology to review diagnostic challenges, evolving disease classifications, histopathologic criteria, and practical approaches to interpreting skin biopsies.\r\n\r\nHeld October 12–15, 2026, at the Fairmont Kea Lani on the Wailea Coast of Maui, Hawaii, the course features 20 expert-led presentations addressing medical dermatology, surgical pathology, melanocytic lesions, inflammatory patterns, cutaneous infections, and complex clinicopathologic cases.\r\n\r\nThe \u003cstrong\u003eDermatopathology in Paradise 2026\u003c\/strong\u003e program is directed by \u003cstrong\u003ePhilip E. LeBoit, MD\u003c\/strong\u003e, with additional presentations by Maxwell A. Fung, MD; Joyce S. Lee, MD; and Daniel D. Miller, MD.\r\n\r\nThe curriculum examines important diagnostic problems involving spongiotic and psoriasiform dermatitis, eosinophil-rich inflammatory diseases, infectious dermatoses, occlusive vasculopathies, vascular anomalies, scarring and non-scarring alopecia, cutaneous lymphoma, pediatric tumors, dysplastic nevi, melanoma in situ, and melanocytic lesions occurring at special anatomic sites.\r\n\r\nThe educational program emphasizes histopathologic pattern recognition, diagnostic accuracy, clinicopathologic correlation, selection of appropriate ancillary studies, and avoidance of common interpretive pitfalls.\r\n\r\nThrough challenging case presentations, expert lectures, and practical microscopic diagnostic discussions, the symposium provides a structured review of conditions frequently encountered in dermatopathology and surgical pathology practice.\r\n\u003ch2\u003eCourse Details\u003c\/h2\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eCourse:\u003c\/strong\u003e Scientific Symposiums International Dermatopathology in Paradise Medical Dermatology to Melanocytic Tumors 2026\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOfficial Program:\u003c\/strong\u003e Dermatopathology in Paradise: Medical Dermatology to Melanocytic Tumors\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOrganizer:\u003c\/strong\u003e Scientific Symposiums International (SSI)\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eDates:\u003c\/strong\u003e October 12–15, 2026\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLocation:\u003c\/strong\u003e Wailea Coast, Maui, Hawaii, USA\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eVenue:\u003c\/strong\u003e Fairmont Kea Lani\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOfficial Conference Format:\u003c\/strong\u003e In-Person Continuing Medical Education\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eDuration:\u003c\/strong\u003e Four Days\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003ePublished Scientific Lectures:\u003c\/strong\u003e 20\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003ePrimary Specialty:\u003c\/strong\u003e Dermatopathology\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eAdditional Focus:\u003c\/strong\u003e Pathology, Dermatology, Surgical Pathology, Pediatric Dermatology, Oncology, Infectious Dermatology and Hematopathology\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eLanguage:\u003c\/strong\u003e English\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eCourse Director:\u003c\/strong\u003e Philip E. LeBoit, MD\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eOfficial Accreditation:\u003c\/strong\u003e 20 CME Hours\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eEducational Approach:\u003c\/strong\u003e Expert Lectures, Microscopic Diagnostic Reviews, Clinicopathologic Cases and Histopathologic Pattern Recognition\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational program is designed for physicians and pathology professionals seeking advanced diagnostic updates in dermatopathology.\r\n\r\nThe original SSI conference accreditation applies to eligible registered participants and is separate from educational files offered through MedicalAmboss.\r\n\u003ch2\u003eTarget Audience\u003c\/h2\u003e\r\nThe program is designed for physicians, specialists, and medical trainees involved in the diagnosis and management of inflammatory, infectious, neoplastic, and other dermatologic diseases.\r\n\r\nThe target audience includes:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eDermatopathologists\u003c\/li\u003e\r\n \t\u003cli\u003eGeneral Pathologists\u003c\/li\u003e\r\n \t\u003cli\u003eSurgical Pathologists\u003c\/li\u003e\r\n \t\u003cli\u003eDermatologists\u003c\/li\u003e\r\n \t\u003cli\u003ePediatric Dermatologists\u003c\/li\u003e\r\n \t\u003cli\u003eMedical Oncologists\u003c\/li\u003e\r\n \t\u003cli\u003eHematopathologists\u003c\/li\u003e\r\n \t\u003cli\u003eInfectious Disease Specialists\u003c\/li\u003e\r\n \t\u003cli\u003eDermatologic Surgeons\u003c\/li\u003e\r\n \t\u003cli\u003eMohs Surgeons\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Dermatology Specialists\u003c\/li\u003e\r\n \t\u003cli\u003ePathology Residents\u003c\/li\u003e\r\n \t\u003cli\u003eDermatology Residents\u003c\/li\u003e\r\n \t\u003cli\u003eDermatopathology Fellows\u003c\/li\u003e\r\n \t\u003cli\u003eSurgical Pathology Fellows\u003c\/li\u003e\r\n \t\u003cli\u003eOther Healthcare Professionals Involved in Skin Disease Diagnosis\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe course is particularly relevant to clinicians seeking improvements in microscopic interpretation, diagnostic classification, evaluation of melanocytic lesions, and clinicopathologic correlation.\r\n\u003ch2\u003eProgram Overview\u003c\/h2\u003e\r\nDermatopathology requires integration of tissue morphology, clinical presentation, anatomical location, disease history, and appropriate ancillary testing.\r\n\r\nMany skin disorders share overlapping histopathologic patterns, making accurate diagnosis dependent on recognizing subtle morphological features and understanding clinical context.\r\n\r\nThe \u003cstrong\u003eScientific Symposiums International Dermatopathology in Paradise 2026\u003c\/strong\u003e curriculum addresses these challenges through 20 focused educational presentations.\r\n\r\nThe program covers:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSpongiotic Dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003ePsoriasiform Dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Skin Disease\u003c\/li\u003e\r\n \t\u003cli\u003eUnusual Inflammatory Dermatoses\u003c\/li\u003e\r\n \t\u003cli\u003eEosinophil-Rich Dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous Infections\u003c\/li\u003e\r\n \t\u003cli\u003eInfectious Disease Mimics\u003c\/li\u003e\r\n \t\u003cli\u003eMedical Dermatology\u003c\/li\u003e\r\n \t\u003cli\u003eChallenging Clinicopathologic Cases\u003c\/li\u003e\r\n \t\u003cli\u003eMelanocytic Neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eDysplastic Nevi\u003c\/li\u003e\r\n \t\u003cli\u003eMelanoma in Situ\u003c\/li\u003e\r\n \t\u003cli\u003eMelanocytic Lesions at Special Sites\u003c\/li\u003e\r\n \t\u003cli\u003eHistologic Diagnostic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003eVascular Anomalies\u003c\/li\u003e\r\n \t\u003cli\u003eOcclusive Vasculitis\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous Vasculopathy\u003c\/li\u003e\r\n \t\u003cli\u003eNon-Scarring Alopecia\u003c\/li\u003e\r\n \t\u003cli\u003eScarring Alopecia\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous Lymphoma\u003c\/li\u003e\r\n \t\u003cli\u003eReactive Lymphoid Infiltrates\u003c\/li\u003e\r\n \t\u003cli\u003ePediatric Skin Tumors\u003c\/li\u003e\r\n \t\u003cli\u003eInpatient Dermatopathology\u003c\/li\u003e\r\n \t\u003cli\u003eImmunobullous Diseases\u003c\/li\u003e\r\n \t\u003cli\u003eAncillary Diagnostic Testing\u003c\/li\u003e\r\n \t\u003cli\u003eAppropriate Use Criteria\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Pattern Recognition\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational emphasis is on improving diagnostic precision and developing practical approaches to challenging skin biopsy interpretation.\r\n\u003ch2\u003eLearning Objectives\u003c\/h2\u003e\r\nAfter completing the educational program, participants should be better able to:\r\n\u003col start=\"1\" data-spread=\"true\"\u003e\r\n \t\u003cli\u003eDifferentiate spongiotic and psoriasiform dermatitis using key histopathologic features and appropriate clinicopathologic correlation.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize unusual variants of common inflammatory skin diseases and avoid interpretive errors caused by overlapping morphological patterns.\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify the histological features of cutaneous infections and distinguish them from noninfectious inflammatory and neoplastic mimics.\u003c\/li\u003e\r\n \t\u003cli\u003eApply appropriate diagnostic criteria when evaluating melanocytic nevi, dysplastic nevi, melanoma in situ, and melanocytic lesions at special anatomical sites.\u003c\/li\u003e\r\n \t\u003cli\u003eRecognize important diagnostic pitfalls involving melanocytic tumors and use calibrated histopathologic criteria to improve consistency.\u003c\/li\u003e\r\n \t\u003cli\u003eIdentify histopathologic features associated with scarring and non-scarring alopecia.\u003c\/li\u003e\r\n \t\u003cli\u003eEvaluate vascular anomalies, occlusive vasculitis, and vasculopathies through appropriate morphological assessment and clinical correlation.\u003c\/li\u003e\r\n \t\u003cli\u003eDistinguish cutaneous lymphomas from reactive lymphoid infiltrates and recognize common diagnostic challenges in lymphoid skin pathology.\u003c\/li\u003e\r\n \t\u003cli\u003eAssess challenging pediatric cutaneous tumors and interpret complex inpatient dermatopathology findings.\u003c\/li\u003e\r\n \t\u003cli\u003eApply contemporary diagnostic approaches to immunobullous diseases and other inflammatory disorders.\u003c\/li\u003e\r\n \t\u003cli\u003eSelect appropriate ancillary investigations using relevant Appropriate Use Criteria in dermatopathology.\u003c\/li\u003e\r\n \t\u003cli\u003eImprove microscopic diagnostic reasoning through pattern recognition, case-based interpretation, and examination at different magnifications.\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch1\u003eOfficial Program Topics\u003c\/h1\u003e\r\n\u003ch2\u003eDay 1 – Monday, October 12, 2026\u003c\/h2\u003e\r\n\u003ch2\u003eSession I – Inflammatory Dermatopathology\u003c\/h2\u003e\r\n\u003ch3\u003e1. Spongiotic and Psoriasiform Dermatitis\u003c\/h3\u003e\r\n\u003cstrong\u003e7:30 AM – 8:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Maxwell A. Fung, MD\r\n\r\nThis presentation reviews two major histopathologic reaction patterns encountered in inflammatory skin disease.\r\n\r\nSpongiotic and psoriasiform changes occur in a variety of dermatologic conditions and may present overlapping microscopic findings.\r\n\r\nImportant diagnostic considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSpongiotic Dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003ePsoriasiform Dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003eEpidermal Spongiosis\u003c\/li\u003e\r\n \t\u003cli\u003eEpidermal Hyperplasia\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Infiltrates\u003c\/li\u003e\r\n \t\u003cli\u003eEczematous Disorders\u003c\/li\u003e\r\n \t\u003cli\u003ePsoriasis\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Reaction Patterns\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eClinicopathologic Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eMicroscopic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Interpretation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes distinguishing common inflammatory patterns through systematic microscopic examination.\r\n\u003ch3\u003e2. Cutaneous Infections and Their Mimics\u003c\/h3\u003e\r\n\u003cstrong\u003e8:30 AM – 9:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Daniel D. Miller, MD\r\n\r\nThis presentation examines histopathologic features of skin infections and conditions that may resemble infectious dermatoses.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCutaneous Infections\u003c\/li\u003e\r\n \t\u003cli\u003eBacterial Skin Disease\u003c\/li\u003e\r\n \t\u003cli\u003eFungal Infections\u003c\/li\u003e\r\n \t\u003cli\u003eViral Dermatoses\u003c\/li\u003e\r\n \t\u003cli\u003eParasitic Skin Conditions\u003c\/li\u003e\r\n \t\u003cli\u003eInfectious Granulomatous Inflammation\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Patterns\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Mimics\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Stains\u003c\/li\u003e\r\n \t\u003cli\u003eMicrobiological Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eTissue Biopsy Interpretation\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational focus is on recognizing infectious patterns while avoiding misclassification of noninfectious disorders.\r\n\u003ch2\u003eSession II – Medical Dermatology and Melanocytic Pathology\u003c\/h2\u003e\r\n\u003ch3\u003e3. Medical Dermatology: A Tour Through Challenging Cases and Emerging Entities\u003c\/h3\u003e\r\n\u003cstrong\u003e9:30 AM – 10:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Joyce S. Lee, MD\r\n\r\nThis session examines challenging medical dermatology cases and emerging disease entities.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eComplex Dermatologic Presentations\u003c\/li\u003e\r\n \t\u003cli\u003eEmerging Skin Disease Entities\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Dermatoses\u003c\/li\u003e\r\n \t\u003cli\u003eClinical-Pathological Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Uncertainty\u003c\/li\u003e\r\n \t\u003cli\u003eHistological Pattern Recognition\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eUnusual Clinical Presentations\u003c\/li\u003e\r\n \t\u003cli\u003eAppropriate Diagnostic Investigation\u003c\/li\u003e\r\n \t\u003cli\u003eCase-Based Interpretation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes integrating clinical findings with microscopic morphology.\r\n\u003ch3\u003e4. Melanocytic Do's and Don'ts\u003c\/h3\u003e\r\n\u003cstrong\u003e11:00 AM – 12:00 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Philip E. LeBoit, MD\r\n\r\nThis presentation reviews practical principles for diagnosing melanocytic lesions while avoiding common histopathologic pitfalls.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMelanocytic Nevi\u003c\/li\u003e\r\n \t\u003cli\u003eMelanocytic Proliferations\u003c\/li\u003e\r\n \t\u003cli\u003eBenign Versus Malignant Features\u003c\/li\u003e\r\n \t\u003cli\u003eCytological Atypia\u003c\/li\u003e\r\n \t\u003cli\u003eArchitectural Atypia\u003c\/li\u003e\r\n \t\u003cli\u003eMelanoma\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003eHistologic Criteria\u003c\/li\u003e\r\n \t\u003cli\u003eClinicopathologic Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Reporting\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes careful interpretation of melanocytic lesions and recognition of findings requiring further assessment.\r\n\u003ch3\u003e5. Potpourri of Memorable Cases\u003c\/h3\u003e\r\n\u003cstrong\u003e12:00 PM – 1:00 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Joyce S. Lee, MD\r\n\r\nThis case-based presentation reviews memorable and diagnostically challenging dermatopathology cases.\r\n\r\nImportant themes include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eUnusual Clinical Presentations\u003c\/li\u003e\r\n \t\u003cli\u003eChallenging Histological Findings\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003ePattern Recognition\u003c\/li\u003e\r\n \t\u003cli\u003eClinicopathologic Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Reasoning\u003c\/li\u003e\r\n \t\u003cli\u003eRare Skin Disorders\u003c\/li\u003e\r\n \t\u003cli\u003ePractical Diagnostic Lessons\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe case-based format supports the application of morphological knowledge to real-world diagnostic problems.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eDay 2 – Tuesday, October 13, 2026\u003c\/h2\u003e\r\n\u003ch2\u003eSession III – Inflammatory Skin Disease and Ancillary Testing\u003c\/h2\u003e\r\n\u003ch3\u003e6. Unusual Variants of Common Inflammatory Skin Diseases\u003c\/h3\u003e\r\n\u003cstrong\u003e7:30 AM – 8:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Philip E. LeBoit, MD\r\n\r\nThis session examines uncommon presentations and histopathologic variants of frequently encountered inflammatory dermatoses.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eInflammatory Skin Disease\u003c\/li\u003e\r\n \t\u003cli\u003eUnusual Histological Variants\u003c\/li\u003e\r\n \t\u003cli\u003eAtypical Morphology\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Overlap\u003c\/li\u003e\r\n \t\u003cli\u003ePattern Recognition\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Interpretation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation highlights the importance of recognizing variations that may complicate routine diagnosis.\r\n\u003ch3\u003e7. To Test or Not to Test: Appropriate Use Criteria in Dermatopathology\u003c\/h3\u003e\r\n\u003cstrong\u003e8:30 AM – 9:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Maxwell A. Fung, MD\r\n\r\nThis presentation examines the appropriate selection of ancillary studies in dermatopathology.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAppropriate Use Criteria\u003c\/li\u003e\r\n \t\u003cli\u003eAncillary Testing\u003c\/li\u003e\r\n \t\u003cli\u003eImmunohistochemistry\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular Testing\u003c\/li\u003e\r\n \t\u003cli\u003eSpecial Stains\u003c\/li\u003e\r\n \t\u003cli\u003eTest Selection\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Yield\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Utility\u003c\/li\u003e\r\n \t\u003cli\u003eResource Utilization\u003c\/li\u003e\r\n \t\u003cli\u003eAvoiding Unnecessary Testing\u003c\/li\u003e\r\n \t\u003cli\u003eEvidence-Based Diagnostic Practice\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational emphasis is on selecting tests that meaningfully contribute to diagnostic accuracy.\r\n\u003ch2\u003eSession IV – Vascular Disorders and Clinical Cases\u003c\/h2\u003e\r\n\u003ch3\u003e8. Histology of Vascular Anomalies\u003c\/h3\u003e\r\n\u003cstrong\u003e9:30 AM – 10:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Daniel D. Miller, MD\r\n\r\nThis presentation reviews the histopathology of vascular anomalies affecting the skin and soft tissues.\r\n\r\nImportant diagnostic considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eVascular Anomalies\u003c\/li\u003e\r\n \t\u003cli\u003eVascular Malformations\u003c\/li\u003e\r\n \t\u003cli\u003eVascular Tumors\u003c\/li\u003e\r\n \t\u003cli\u003eCapillary Lesions\u003c\/li\u003e\r\n \t\u003cli\u003eVenous Lesions\u003c\/li\u003e\r\n \t\u003cli\u003eLymphatic Abnormalities\u003c\/li\u003e\r\n \t\u003cli\u003eHistological Classification\u003c\/li\u003e\r\n \t\u003cli\u003eEndothelial Morphology\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Interpretation\u003c\/li\u003e\r\n \t\u003cli\u003eClinicopathologic Correlation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session explores recognition and differentiation of vascular lesions.\r\n\u003ch3\u003e9. Clogged Clues: Occlusive Vasculitis and Vasculopathy\u003c\/h3\u003e\r\n\u003cstrong\u003e11:00 AM – 12:00 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Joyce S. Lee, MD\r\n\r\nThis session examines skin disorders involving vascular inflammation, occlusion, and associated tissue injury.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCutaneous Vasculitis\u003c\/li\u003e\r\n \t\u003cli\u003eOcclusive Vasculopathy\u003c\/li\u003e\r\n \t\u003cli\u003eVascular Thrombosis\u003c\/li\u003e\r\n \t\u003cli\u003eEndothelial Injury\u003c\/li\u003e\r\n \t\u003cli\u003eTissue Ischemia\u003c\/li\u003e\r\n \t\u003cli\u003eVascular Inflammation\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Patterns\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes recognition of findings that distinguish inflammatory vascular injury from noninflammatory occlusive processes.\r\n\u003ch3\u003e10. Challenging Clinicopathologic Cases\u003c\/h3\u003e\r\n\u003cstrong\u003e12:00 PM – 1:00 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Daniel D. Miller, MD\r\n\r\nThis case-based session explores complex diagnostic scenarios requiring integration of clinical information and tissue findings.\r\n\r\nImportant themes include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eClinicopathologic Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eHistologic Pattern Recognition\u003c\/li\u003e\r\n \t\u003cli\u003eComplex Skin Lesions\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Uncertainty\u003c\/li\u003e\r\n \t\u003cli\u003eAppropriate Ancillary Testing\u003c\/li\u003e\r\n \t\u003cli\u003eClinical History\u003c\/li\u003e\r\n \t\u003cli\u003eMicroscopic Interpretation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes systematic reasoning in challenging dermatopathology cases.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eDay 3 – Wednesday, October 14, 2026\u003c\/h2\u003e\r\n\u003ch2\u003eSession V – Hair Disorders and Cutaneous Lymphoma\u003c\/h2\u003e\r\n\u003ch3\u003e11. Pitfalls and Pearls in Non-Scarring Alopecia\u003c\/h3\u003e\r\n\u003cstrong\u003e7:30 AM – 8:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Joyce S. Lee, MD\r\n\r\nThis presentation reviews the histopathologic evaluation of non-scarring hair loss.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eNon-Scarring Alopecia\u003c\/li\u003e\r\n \t\u003cli\u003eHair Follicle Biology\u003c\/li\u003e\r\n \t\u003cli\u003eHair Cycle Changes\u003c\/li\u003e\r\n \t\u003cli\u003eAlopecia Areata\u003c\/li\u003e\r\n \t\u003cli\u003eTelogen Effluvium\u003c\/li\u003e\r\n \t\u003cli\u003ePattern Hair Loss\u003c\/li\u003e\r\n \t\u003cli\u003eScalp Biopsy\u003c\/li\u003e\r\n \t\u003cli\u003eFollicular Density\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes recognizing characteristic microscopic findings in common causes of non-scarring alopecia.\r\n\u003ch3\u003e12. Pitfalls in the Diagnosis of Cutaneous Lymphoma\u003c\/h3\u003e\r\n\u003cstrong\u003e8:30 AM – 9:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Philip E. LeBoit, MD\r\n\r\nThis presentation examines important diagnostic challenges involving lymphoid infiltrates of the skin.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCutaneous Lymphoma\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous T-Cell Lymphoma\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous B-Cell Lymphoma\u003c\/li\u003e\r\n \t\u003cli\u003eMycosis Fungoides\u003c\/li\u003e\r\n \t\u003cli\u003eReactive Lymphoid Infiltrates\u003c\/li\u003e\r\n \t\u003cli\u003eLymphocytic Atypia\u003c\/li\u003e\r\n \t\u003cli\u003eEpidermotropism\u003c\/li\u003e\r\n \t\u003cli\u003eImmunophenotyping\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular Studies\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003eClinicopathologic Correlation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational focus is on distinguishing malignant lymphoid disorders from reactive inflammatory processes.\r\n\u003ch2\u003eSession VI – Eosinophilic Dermatoses and Pediatric Tumors\u003c\/h2\u003e\r\n\u003ch3\u003e13. The Role of Eosinophils in the Differential Diagnosis of Inflammatory Skin Disease\u003c\/h3\u003e\r\n\u003cstrong\u003e9:30 AM – 10:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Maxwell A. Fung, MD\r\n\r\nThis session examines eosinophil-rich inflammatory patterns and their role in dermatopathologic diagnosis.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eEosinophilic Inflammation\u003c\/li\u003e\r\n \t\u003cli\u003eEosinophil-Rich Dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003eAllergic Skin Reactions\u003c\/li\u003e\r\n \t\u003cli\u003eDrug Eruptions\u003c\/li\u003e\r\n \t\u003cli\u003eArthropod Reactions\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Patterns\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Clues\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Correlation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes the interpretation of eosinophils within the broader pattern of tissue inflammation.\r\n\u003ch3\u003e14. Challenging Pediatric Tumors\u003c\/h3\u003e\r\n\u003cstrong\u003e11:00 AM – 12:00 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Daniel D. Miller, MD\r\n\r\nThis presentation reviews diagnostically challenging tumors occurring in pediatric patients.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePediatric Dermatopathology\u003c\/li\u003e\r\n \t\u003cli\u003ePediatric Skin Tumors\u003c\/li\u003e\r\n \t\u003cli\u003eBenign Cutaneous Neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eMalignant Cutaneous Neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eAge-Specific Histopathology\u003c\/li\u003e\r\n \t\u003cli\u003eUnusual Tumor Morphology\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eAncillary Testing\u003c\/li\u003e\r\n \t\u003cli\u003eClinicopathologic Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session supports accurate assessment of skin tumors in children.\r\n\u003ch3\u003e15. Dysplastic Nevi and Melanoma in Situ: Criteria for Calibration\u003c\/h3\u003e\r\n\u003cstrong\u003e12:00 PM – 1:00 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Philip E. LeBoit, MD\r\n\r\nThis presentation examines diagnostic criteria used to assess dysplastic melanocytic nevi and melanoma in situ.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eDysplastic Nevi\u003c\/li\u003e\r\n \t\u003cli\u003eMelanoma in Situ\u003c\/li\u003e\r\n \t\u003cli\u003eMelanocytic Atypia\u003c\/li\u003e\r\n \t\u003cli\u003eArchitectural Disorder\u003c\/li\u003e\r\n \t\u003cli\u003eCytologic Atypia\u003c\/li\u003e\r\n \t\u003cli\u003eJunctional Melanocytic Proliferations\u003c\/li\u003e\r\n \t\u003cli\u003eHistologic Diagnostic Criteria\u003c\/li\u003e\r\n \t\u003cli\u003eInterobserver Variation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Calibration\u003c\/li\u003e\r\n \t\u003cli\u003eAppropriate Reporting\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes consistency and precision in melanocytic lesion interpretation.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eDay 4 – Thursday, October 15, 2026\u003c\/h2\u003e\r\n\u003ch2\u003eSession VII – Inpatient Dermatopathology and Immunobullous Disease\u003c\/h2\u003e\r\n\u003ch3\u003e16. Inpatient Dermatopathology\u003c\/h3\u003e\r\n\u003cstrong\u003e7:30 AM – 8:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Daniel D. Miller, MD\r\n\r\nThis presentation reviews skin disorders encountered among hospitalized patients.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eInpatient Dermatology\u003c\/li\u003e\r\n \t\u003cli\u003eAcute Cutaneous Eruptions\u003c\/li\u003e\r\n \t\u003cli\u003eDrug-Related Skin Disease\u003c\/li\u003e\r\n \t\u003cli\u003eSevere Inflammatory Dermatoses\u003c\/li\u003e\r\n \t\u003cli\u003eInfectious Dermatoses\u003c\/li\u003e\r\n \t\u003cli\u003eSkin Biopsy Interpretation\u003c\/li\u003e\r\n \t\u003cli\u003eClinicopathologic Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Prioritization\u003c\/li\u003e\r\n \t\u003cli\u003eUrgent Dermatopathology\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Consultation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes the diagnostic challenges associated with complex hospitalized patients.\r\n\u003ch3\u003e17. Immunobullous Disease: What's New in 2026\u003c\/h3\u003e\r\n\u003cstrong\u003e8:30 AM – 9:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Maxwell A. Fung, MD\r\n\r\nThis presentation examines diagnostic developments in autoimmune blistering skin disorders.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eImmunobullous Diseases\u003c\/li\u003e\r\n \t\u003cli\u003ePemphigus\u003c\/li\u003e\r\n \t\u003cli\u003eBullous Pemphigoid\u003c\/li\u003e\r\n \t\u003cli\u003eAutoimmune Blistering Disorders\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Evaluation\u003c\/li\u003e\r\n \t\u003cli\u003eIntraepidermal Blistering\u003c\/li\u003e\r\n \t\u003cli\u003eSubepidermal Blistering\u003c\/li\u003e\r\n \t\u003cli\u003eDirect Immunofluorescence\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Testing\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eUpdated Diagnostic Approaches\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational focus is on integrating routine histopathology with appropriate immunologic testing.\r\n\u003ch2\u003eSession VIII – Scarring Alopecia and Melanocytic Lesions\u003c\/h2\u003e\r\n\u003ch3\u003e18. Pitfalls and Pearls in Scarring Alopecia\u003c\/h3\u003e\r\n\u003cstrong\u003e9:30 AM – 10:30 AM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Joyce S. Lee, MD\r\n\r\nThis session reviews diagnostic approaches to scarring hair loss.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCicatricial Alopecia\u003c\/li\u003e\r\n \t\u003cli\u003eFollicular Destruction\u003c\/li\u003e\r\n \t\u003cli\u003eScalp Inflammation\u003c\/li\u003e\r\n \t\u003cli\u003eLichen Planopilaris\u003c\/li\u003e\r\n \t\u003cli\u003eFrontal Fibrosing Alopecia\u003c\/li\u003e\r\n \t\u003cli\u003eDiscoid Lupus Erythematosus\u003c\/li\u003e\r\n \t\u003cli\u003eFollicular Fibrosis\u003c\/li\u003e\r\n \t\u003cli\u003eScalp Biopsy\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Patterns\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session emphasizes recognition of processes that may result in irreversible follicular damage.\r\n\u003ch3\u003e19. Nevi and Melanomas at Special Sites\u003c\/h3\u003e\r\n\u003cstrong\u003e11:00 AM – 12:00 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Philip E. LeBoit, MD\r\n\r\nThis presentation examines melanocytic lesions occurring at anatomical sites where benign nevi may display unusual histological features.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSpecial-Site Nevi\u003c\/li\u003e\r\n \t\u003cli\u003eMelanocytic Neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eMelanoma\u003c\/li\u003e\r\n \t\u003cli\u003eSite-Related Histological Variation\u003c\/li\u003e\r\n \t\u003cli\u003eAcral Melanocytic Lesions\u003c\/li\u003e\r\n \t\u003cli\u003eGenital Melanocytic Lesions\u003c\/li\u003e\r\n \t\u003cli\u003eUnusual Cytological Findings\u003c\/li\u003e\r\n \t\u003cli\u003eArchitectural Atypia\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eMelanoma Mimics\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe presentation emphasizes accurate interpretation of melanocytic lesions in relation to anatomical context.\r\n\u003ch3\u003e20. Spot Diagnoses from Low to High Power\u003c\/h3\u003e\r\n\u003cstrong\u003e12:00 PM – 1:00 PM\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFaculty:\u003c\/strong\u003e Maxwell A. Fung, MD\r\n\r\nThis concluding presentation emphasizes microscopic pattern recognition and diagnostic reasoning across multiple magnifications.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eLow-Power Pattern Recognition\u003c\/li\u003e\r\n \t\u003cli\u003eHigh-Power Histologic Features\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Clues\u003c\/li\u003e\r\n \t\u003cli\u003eArchitectural Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eCytological Interpretation\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eRapid Pattern Recognition\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eCommon Diagnostic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003ePractical Dermatopathology\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe session reinforces an organized approach to tissue examination and diagnostic interpretation.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eMajor Topics Covered\u003c\/h2\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eSSI Dermatopathology in Paradise 2026\u003c\/li\u003e\r\n \t\u003cli\u003eMedical Dermatology\u003c\/li\u003e\r\n \t\u003cli\u003eDermatopathology\u003c\/li\u003e\r\n \t\u003cli\u003eSurgical Pathology\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Skin Diseases\u003c\/li\u003e\r\n \t\u003cli\u003eSpongiotic Dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003ePsoriasiform Dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003ePsoriasis\u003c\/li\u003e\r\n \t\u003cli\u003eEczematous Dermatitis\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous Infections\u003c\/li\u003e\r\n \t\u003cli\u003eInfectious Mimics\u003c\/li\u003e\r\n \t\u003cli\u003eDermatologic Histopathology\u003c\/li\u003e\r\n \t\u003cli\u003eMelanocytic Neoplasms\u003c\/li\u003e\r\n \t\u003cli\u003eMelanocytic Nevi\u003c\/li\u003e\r\n \t\u003cli\u003eDysplastic Nevi\u003c\/li\u003e\r\n \t\u003cli\u003eMelanoma in Situ\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous Melanoma\u003c\/li\u003e\r\n \t\u003cli\u003eSpecial-Site Nevi\u003c\/li\u003e\r\n \t\u003cli\u003eClinicopathologic Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Diagnostic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003eAncillary Testing\u003c\/li\u003e\r\n \t\u003cli\u003eAppropriate Use Criteria\u003c\/li\u003e\r\n \t\u003cli\u003eVascular Anomalies\u003c\/li\u003e\r\n \t\u003cli\u003eVascular Malformations\u003c\/li\u003e\r\n \t\u003cli\u003eVasculitis\u003c\/li\u003e\r\n \t\u003cli\u003eOcclusive Vasculopathy\u003c\/li\u003e\r\n \t\u003cli\u003eHair Follicle Pathology\u003c\/li\u003e\r\n \t\u003cli\u003eNon-Scarring Alopecia\u003c\/li\u003e\r\n \t\u003cli\u003eScarring Alopecia\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous Lymphoma\u003c\/li\u003e\r\n \t\u003cli\u003eMycosis Fungoides\u003c\/li\u003e\r\n \t\u003cli\u003eReactive Lymphoid Infiltrates\u003c\/li\u003e\r\n \t\u003cli\u003eEosinophilic Dermatoses\u003c\/li\u003e\r\n \t\u003cli\u003ePediatric Skin Tumors\u003c\/li\u003e\r\n \t\u003cli\u003eInpatient Dermatopathology\u003c\/li\u003e\r\n \t\u003cli\u003eImmunobullous Disease\u003c\/li\u003e\r\n \t\u003cli\u003ePemphigus\u003c\/li\u003e\r\n \t\u003cli\u003eBullous Pemphigoid\u003c\/li\u003e\r\n \t\u003cli\u003eDirect Immunofluorescence\u003c\/li\u003e\r\n \t\u003cli\u003eMicroscopic Pattern Recognition\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Diagnosis\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eInflammatory Dermatopathology\u003c\/h2\u003e\r\nInflammatory skin diseases represent a major component of routine dermatopathology practice.\r\n\r\nDifferent disorders may share overlapping histological features, making accurate interpretation dependent on the recognition of reaction patterns and careful clinical correlation.\r\n\r\nThe curriculum examines spongiotic dermatitis, psoriasiform inflammation, unusual variants of common dermatoses, and eosinophil-rich inflammatory disorders.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eEpidermal Reaction Patterns\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Cell Distribution\u003c\/li\u003e\r\n \t\u003cli\u003eSpongiosis\u003c\/li\u003e\r\n \t\u003cli\u003ePsoriasiform Hyperplasia\u003c\/li\u003e\r\n \t\u003cli\u003eEosinophilic Infiltrates\u003c\/li\u003e\r\n \t\u003cli\u003eHistologic Variants\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational focus supports systematic interpretation of inflammatory skin biopsies.\r\n\u003ch2\u003eMelanocytic Neoplasms and Melanoma Diagnosis\u003c\/h2\u003e\r\nMelanocytic lesion interpretation is one of the most challenging areas of dermatopathology.\r\n\r\nBenign nevi, dysplastic nevi, melanoma in situ, and special-site melanocytic lesions may demonstrate overlapping architectural and cytological features.\r\n\r\nThe course addresses:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eMelanocytic Lesion Classification\u003c\/li\u003e\r\n \t\u003cli\u003eCytological Atypia\u003c\/li\u003e\r\n \t\u003cli\u003eArchitectural Disorder\u003c\/li\u003e\r\n \t\u003cli\u003eDysplastic Nevi\u003c\/li\u003e\r\n \t\u003cli\u003eMelanoma in Situ\u003c\/li\u003e\r\n \t\u003cli\u003eSpecial-Site Lesions\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Criteria\u003c\/li\u003e\r\n \t\u003cli\u003eHistologic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003eAppropriate Reporting\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nMultiple presentations by Philip E. LeBoit focus on improving precision in melanocytic diagnosis.\r\n\u003ch2\u003eCutaneous Lymphoma and Lymphoid Infiltrates\u003c\/h2\u003e\r\nThe diagnosis of cutaneous lymphoma requires careful evaluation of tissue architecture, cytological features, clinical findings, and appropriate ancillary investigations.\r\n\r\nReactive lymphoid infiltrates may resemble lymphoid malignancies.\r\n\r\nThe curriculum reviews important diagnostic considerations involving:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eCutaneous T-Cell Lymphoma\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous B-Cell Lymphoma\u003c\/li\u003e\r\n \t\u003cli\u003eMycosis Fungoides\u003c\/li\u003e\r\n \t\u003cli\u003eReactive Lymphoid Infiltrates\u003c\/li\u003e\r\n \t\u003cli\u003eImmunophenotyping\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular Testing\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003eClinicopathologic Correlation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe educational emphasis is on accurate differentiation between malignant and reactive processes.\r\n\u003ch2\u003eHair Disorders and Alopecia\u003c\/h2\u003e\r\nHair loss can result from inflammatory, autoimmune, hormonal, and other mechanisms.\r\n\r\nScalp biopsy interpretation requires knowledge of follicular anatomy, hair cycles, inflammatory patterns, and fibrosis.\r\n\r\nThe program includes dedicated sessions on both scarring and non-scarring alopecia.\r\n\r\nImportant areas include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eHair Follicle Histology\u003c\/li\u003e\r\n \t\u003cli\u003eHair Cycle Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eAlopecia Areata\u003c\/li\u003e\r\n \t\u003cli\u003ePattern Hair Loss\u003c\/li\u003e\r\n \t\u003cli\u003eCicatricial Alopecia\u003c\/li\u003e\r\n \t\u003cli\u003eFollicular Inflammation\u003c\/li\u003e\r\n \t\u003cli\u003eFollicular Fibrosis\u003c\/li\u003e\r\n \t\u003cli\u003eScalp Biopsy Interpretation\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Pitfalls\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eVascular Disorders of the Skin\u003c\/h2\u003e\r\nCutaneous vascular disorders may involve developmental vascular anomalies, inflammatory vascular injury, or noninflammatory occlusive processes.\r\n\r\nThe course examines histological clues relevant to these disorders.\r\n\r\nImportant topics include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eVascular Anomalies\u003c\/li\u003e\r\n \t\u003cli\u003eVascular Tumors\u003c\/li\u003e\r\n \t\u003cli\u003eVascular Malformations\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous Vasculitis\u003c\/li\u003e\r\n \t\u003cli\u003eOcclusive Vasculopathy\u003c\/li\u003e\r\n \t\u003cli\u003eThrombosis\u003c\/li\u003e\r\n \t\u003cli\u003eIschemic Injury\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThese sessions emphasize the relationship between morphology and clinical presentation.\r\n\u003ch2\u003eImmunobullous Diseases\u003c\/h2\u003e\r\nAutoimmune blistering disorders require accurate identification of blister location, inflammatory patterns, and immunologic findings.\r\n\r\nThe curriculum includes a dedicated 2026 update on immunobullous disease.\r\n\r\nImportant considerations include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePemphigus\u003c\/li\u003e\r\n \t\u003cli\u003eBullous Pemphigoid\u003c\/li\u003e\r\n \t\u003cli\u003eEpidermal Blistering\u003c\/li\u003e\r\n \t\u003cli\u003eSubepidermal Blistering\u003c\/li\u003e\r\n \t\u003cli\u003eDirect Immunofluorescence\u003c\/li\u003e\r\n \t\u003cli\u003eHistopathologic Assessment\u003c\/li\u003e\r\n \t\u003cli\u003eAncillary Testing\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003ePediatric and Inpatient Dermatopathology\u003c\/h2\u003e\r\nPediatric skin tumors and dermatologic conditions encountered in hospitalized patients may present unusual diagnostic challenges.\r\n\r\nThe program includes specific sessions devoted to these settings.\r\n\r\nImportant themes include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003ePediatric Tumor Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eAge-Related Histologic Features\u003c\/li\u003e\r\n \t\u003cli\u003eComplex Inpatient Eruptions\u003c\/li\u003e\r\n \t\u003cli\u003eSevere Inflammatory Conditions\u003c\/li\u003e\r\n \t\u003cli\u003eInfectious Skin Disease\u003c\/li\u003e\r\n \t\u003cli\u003eDrug-Related Dermatoses\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Correlation\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary Consultation\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eAppropriate Use of Diagnostic Testing\u003c\/h2\u003e\r\nModern dermatopathology may incorporate immunohistochemical, microbiological, molecular, and immunofluorescence-based investigations.\r\n\r\nAppropriate test selection requires consideration of diagnostic uncertainty, expected clinical value, and resource utilization.\r\n\r\nThe course includes a dedicated presentation addressing Appropriate Use Criteria.\r\n\r\nImportant concepts include:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eAncillary Test Selection\u003c\/li\u003e\r\n \t\u003cli\u003eImmunohistochemistry\u003c\/li\u003e\r\n \t\u003cli\u003eMolecular Diagnostics\u003c\/li\u003e\r\n \t\u003cli\u003eSpecial Stains\u003c\/li\u003e\r\n \t\u003cli\u003eDirect Immunofluorescence\u003c\/li\u003e\r\n \t\u003cli\u003eClinical Utility\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Accuracy\u003c\/li\u003e\r\n \t\u003cli\u003eAvoidance of Unnecessary Testing\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eHistopathologic Pattern Recognition\u003c\/h2\u003e\r\nThe ability to recognize patterns at different microscopic magnifications is an essential skill in dermatopathology.\r\n\r\nThe curriculum emphasizes:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eLow-Power Tissue Architecture\u003c\/li\u003e\r\n \t\u003cli\u003eHigh-Power Cellular Detail\u003c\/li\u003e\r\n \t\u003cli\u003eInflammatory Patterns\u003c\/li\u003e\r\n \t\u003cli\u003eNeoplastic Morphology\u003c\/li\u003e\r\n \t\u003cli\u003eDiagnostic Clues\u003c\/li\u003e\r\n \t\u003cli\u003eDifferential Diagnosis\u003c\/li\u003e\r\n \t\u003cli\u003eHistologic Pitfalls\u003c\/li\u003e\r\n \t\u003cli\u003eCase-Based Reasoning\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe concluding spot-diagnosis session reinforces these principles.\r\n\u003ch2\u003eCourse Leadership\u003c\/h2\u003e\r\n\u003ch3\u003ePhilip E. LeBoit, MD\u003c\/h3\u003e\r\n\u003cstrong\u003eCourse Director\u003c\/strong\u003e\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eUniversity of California, San Francisco\u003c\/li\u003e\r\n \t\u003cli\u003eCo-Director, UCSF Dermatopathology and Oral Pathology Service\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nDr. LeBoit contributes multiple presentations on inflammatory skin disease, melanocytic tumors, cutaneous lymphoma, and diagnostic pitfalls.\r\n\u003ch2\u003eOfficial Faculty\u003c\/h2\u003e\r\n\u003ch3\u003eMaxwell A. Fung, MD\u003c\/h3\u003e\r\n\u003cstrong\u003eUniversity of California, Davis\u003c\/strong\u003e\r\n\r\nEducational topics include inflammatory dermatitis, eosinophilic skin disease, appropriate diagnostic testing, immunobullous disorders, and microscopic pattern recognition.\r\n\u003ch3\u003eJoyce S. Lee, MD\u003c\/h3\u003e\r\n\u003cstrong\u003eNational Skin Centre, Singapore\u003c\/strong\u003e\r\n\r\nEducational topics include medical dermatology, vascular disorders, alopecia, and challenging clinicopathologic cases.\r\n\u003ch3\u003eDaniel D. Miller, MD\u003c\/h3\u003e\r\n\u003cstrong\u003eUniversity of Minnesota, Twin Cities\u003c\/strong\u003e\r\n\r\nEducational topics include cutaneous infections, vascular anomalies, pediatric skin tumors, inpatient dermatopathology, and complex diagnostic cases.\r\n\u003ch3\u003ePhilip E. LeBoit, MD\u003c\/h3\u003e\r\n\u003cstrong\u003eUniversity of California, San Francisco\u003c\/strong\u003e\r\n\r\nEducational topics include melanocytic lesions, dysplastic nevi, melanoma in situ, cutaneous lymphoma, and inflammatory dermatopathology.\r\n\u003ch2\u003eContinuing Medical Education\u003c\/h2\u003e\r\nScientific Symposiums International lists the original four-day educational course as providing:\r\n\r\n\u003cstrong\u003e20 CME Hours\u003c\/strong\u003e\r\n\r\nThe credit designation relates to eligible participation in the original SSI educational program and is subject to the organizer's accreditation and completion requirements.\r\n\u003ch3\u003eImportant CME Notice\u003c\/h3\u003e\r\nPurchasing separately distributed educational files through MedicalAmboss does not provide:\r\n\u003cul data-spread=\"false\"\u003e\r\n \t\u003cli\u003eOfficial SSI CME Credits\u003c\/li\u003e\r\n \t\u003cli\u003eContinuing Education Certificates\u003c\/li\u003e\r\n \t\u003cli\u003eOfficial Conference Registration\u003c\/li\u003e\r\n \t\u003cli\u003eLive Conference Attendance\u003c\/li\u003e\r\n \t\u003cli\u003ePublisher Streaming Platform Access\u003c\/li\u003e\r\n \t\u003cli\u003eOfficial SSI Accounts\u003c\/li\u003e\r\n \t\u003cli\u003ePublisher Memberships\u003c\/li\u003e\r\n \t\u003cli\u003ePublisher-Hosted Educational Extras\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2\u003eWhy This Course Is Relevant\u003c\/h2\u003e\r\nThe \u003cstrong\u003eScientific Symposiums International Dermatopathology in Paradise Medical Dermatology to Melanocytic Tumors 2026\u003c\/strong\u003e course addresses important diagnostic challenges encountered in dermatopathology and surgical pathology.\r\n\r\nDermatopathologists frequently evaluate skin biopsies involving overlapping inflammatory reactions, infectious organisms, vascular abnormalities, hair loss, lymphoid infiltrates, pediatric neoplasms, and melanocytic proliferations.\r\n\r\nThe program offers a broad educational review of these diagnostic problems.\r\n\r\nIts combination of expert presentations, clinicopathologic cases, microscopic pattern recognition, and discussions of diagnostic pitfalls makes it relevant to practicing dermatopathologists, pathologists, dermatologists, oncology specialists, and dermatology or pathology trainees.\r\n\r\nThe curriculum emphasizes careful histological interpretation, appropriate ancillary testing, and improved diagnostic consistency.\r\n\u003ch2\u003eOfficial Program Reference and MedicalAmboss Purchase Scope\u003c\/h2\u003e\r\n\u003cstrong\u003eOfficial Scientific Symposiums International Course:\u003c\/strong\u003e\r\n\r\n\u003ca href=\"https:\/\/www.scientificsymposiums.com\/dermatopathology-in-paradise-medical-dermatology-to-melanocytic-tumors-course-372.html\" data-rich-text-autolink=\"\"\u003ehttps:\/\/www.scientificsymposiums.com\/dermatopathology-in-paradise-medical-dermatology-to-melanocytic-tumors-course-372.html\u003c\/a\u003e\r\n\r\n\u003cstrong\u003eOfficial 2026 Course Schedule:\u003c\/strong\u003e\r\n\r\n\u003ca href=\"https:\/\/www.scientificsymposiums.com\/pdfs\/course_2026-10-12_372.pdf\" data-rich-text-autolink=\"\"\u003ehttps:\/\/www.scientificsymposiums.com\/pdfs\/course_2026-10-12_372.pdf\u003c\/a\u003e\r\n\r\nThese references describe the original educational program, including conference dates, lecture titles, faculty, location, and accreditation.\r\n\r\nThe original program and publisher-hosted video links do not independently establish which files are included in a separately distributed MedicalAmboss product.\r\n\r\n\u003cstrong\u003eMedicalAmboss File Scope:\u003c\/strong\u003e This listing describes the educational subject matter for reference. Provider registration, live attendance, streaming-platform access, CME or other credit, certificates, memberships, apps, accounts, and publisher-hosted extras are not included unless explicitly listed as store files.\r\n\u003cdiv\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/div\u003e\r\n\u003ch2\u003eShort Description\u003c\/h2\u003e\r\n\u003cstrong\u003eScientific Symposiums International Dermatopathology in Paradise Medical Dermatology to Melanocytic Tumors 2026\u003c\/strong\u003e provides a comprehensive educational review of dermatopathology, inflammatory skin disease, melanocytic tumors, cutaneous infections, vascular disorders, alopecia, cutaneous lymphoma, and advanced skin biopsy interpretation.\r\n\r\nHeld October 12–15, 2026, in Maui, Hawaii, the original course features \u003cstrong\u003e20 expert-led dermatopathology lectures\u003c\/strong\u003e by Philip LeBoit, Maxwell Fung, Joyce Lee, and Daniel Miller.\r\n\u003ch2\u003eTopics\u003c\/h2\u003e\r\n\u003col start=\"1\"\u003e\r\n \t\u003cli\u003eSpongiotic and Psoriasiform Dermatitis (Maxwell Fung M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eCutaneous Infections and Their Mimics (Daniel Miller M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eMedical Dermatology: A Tour Through Challenging Cases and Emerging Entities (Joyce Lee M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eMelanocytic Do’s and Don’ts (Philip LeBoit M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003ePotpourri of Memorable Cases (Joyce Lee M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eUnusual Variants of Common Inflammatory Skin Diseases (Philip LeBoit M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eTo Test or Not to Test: Appropriate Use Critieria in Dermatopathology (Maxwell Fung M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eHistology of Vascular Anomalies (Daniel Miller M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eClogged Clues: Occlusive Vasculitis and Vasculopathy (Joyce Lee M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eChallenging Clinicopathologic Cases (Daniel Miller M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003ePitfalls and Pearls in Non-Scarring Alopecia (Joyce Lee M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003ePitfalls in the Diagnosis of Cutaneous Lymphoma (Philip LeBoit M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eThe Role of Eosinophilis in the Differential Diagnosis of Inflammatory Skin Disease (Maxwell Fung M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eChallenging Pediatric Tumors (Daniel Miller M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eDysplastic Nevi and Melanoma in Situ: Criteria for Calibration (Philip LeBoit M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eInpatient Dermatopathology (Daniel Miller M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eImmunobullous Disease: What’s New in2026 (Maxwell Fung M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003ePitfalls and Pearls in Scarring Alopecia (Joyce Lee M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eNevi and Melanomas at Special Sites (Philip LeBoit M.D.)\u003c\/li\u003e\r\n \t\u003cli\u003eSpot Diagnoses from Low to High Power (Maxwell Fung M.D.)\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e","brand":"Amboss","offers":[{"title":"Default Title","offer_id":67982425194650,"sku":"MED-AMB10542","price":140.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0720\/8619\/2282\/files\/macs-0efe51bcb5-50444-51089-57c1614e72114b0ab391.jpg?v=1793146001","url":"https:\/\/ambosscourse.com\/products\/wc-0efe51bcb5f34c14-50444","provider":"Amboss","version":"1.0","type":"link"}